ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CPIX Cumberland Pharmaceutical Inc

1.68
-0.11 (-6.15%)
Mar 28 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 4,435
Bid Price 1.68
Ask Price 1.94
News -
Day High 1.8677

Low
1.43

52 Week Range

High
2.3587

Day Low 1.69
Company Name Stock Ticker Symbol Market Type
Cumberland Pharmaceutical Inc CPIX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.11 -6.15% 1.68 19:56:59
Open Price Low Price High Price Close Price Prev Close
1.735 1.69 1.8677 1.68 1.79
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
87 4,435 $ 1.80 $ 7,974 - 1.43 - 2.3587
Last Trade Time Type Quantity Stock Price Currency
16:00:00 198 $ 1.68 USD

Cumberland Pharmaceutical Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
24.09M 14.26M - 42.01M -5.57M -0.39 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Cumberland Pharmaceutical News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No CPIX Message Board. Create One! See More Posts on CPIX Message Board See More Message Board Posts

Historical CPIX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.881.891.691.7713,476-0.20-10.64%
1 Month2.232.23281.691.8812,042-0.55-24.66%
3 Months1.982.35871.692.0112,222-0.30-15.15%
6 Months1.872.35871.561.9313,220-0.19-10.16%
1 Year2.022.35871.431.8019,305-0.34-16.83%
3 Years3.237.511.434.93437,123-1.55-47.99%
5 Years5.907.511.434.89272,990-4.22-71.53%

Cumberland Pharmaceutical Description

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology and oncology. The company promotes its approved products through its hospital, field and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived primarily from the product sales of FDA approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, RediTrex, Sancuso, Vaprisol and Vibativ..

Your Recent History

Delayed Upgrade Clock